RxDoctor Payments Data

Leif Rogers

Beverly Hills, CANPI 1649276700

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,250 of the $34,761 with a category attached, or 81.3%. Apyx Medical Corporation accounts for 83.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $24,236 and has fallen 98.6% since, to $338 in 2025.

$34,761in general payments, 2019–2025

Across 172 payments — averaging $202.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Apyx Medical Corporation$29K
  • TELA Bio, Inc.$1K
  • AbbVie$1K
  • Sientra, Inc.$931
  • Tepha Inc$423
  • Revance Therapeutics, Inc.$409
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$28,25081%
  • Food & beverage$6,51119%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →